Show simple item record

dc.contributor.authorKonstandi, Maria
dc.contributor.authorKostakis, Dimitris
dc.contributor.authorHarkitis, Panagiotis
dc.contributor.authorJohnson, Elizabeth O.
dc.contributor.authorMarselos, Marios
dc.contributor.authorAdamidis, Konstantinos
dc.contributor.authorLang, Matti
dc.identifier.otherPubMed ID: 16510159
dc.description.abstractCYP1A2, a principal catalyst for metabolism of various therapeutic drugs and carcinogens, among others, is in part regulated by the stress response. This study was designed to assess whether catecholamines and in particular adrenergic receptor-dependent pathways, modulate benzo(α)pyrene (B(α)P)-induced hepatic CYP1A2. To distinguish between the role of central and peripheral catecholamines in the regulation of CYP1A2 induction, the effect of central and peripheral catecholamine depletion using reserpine was compared to that of peripheral catecholamine depletion using guanethidine. The effects of peripheral adrenaline and L-DOPA administration were also assessed. The results suggest that alterations in central catecholamines modulate 7-methoxyresorufin O-demethylase activity (MROD), CYP1A2 mRNA and protein levels in the B(α)P-induced state. In particular, central catecholamine depletion, dexmedetomidine-induced inhibition of noradrenaline release and blockade of α1-adrenoceptors with prazosin, up-regulated CYP1A2 expression. Phenylephrine and dexmedetomidine-induced up-regulation may be mediated, in part, via peripheral α1- and α2-adrenoceptors, respectively. On the other hand, the L-DOPA-induced increase in central dopaminergic activity was not followed by any change in the up-regulation of CYP1A2 expression by B(α)P. Central noradrenergic systems appeared to counteract up-regulating factors, most likely via α1- and α2-adrenoceptors. In contrast, peripheral alpha- and beta-adrenoceptor-related signaling pathways are linked to up-regulating processes. The findings suggest that drugs that bind to adrenoceptors or affect central noradrenergic neurotransmission, as well as factors that challenge the adrenoceptor-linked signaling pathways may deregulate CYP1A2 induction. This, in turn, may result in drug-therapy and drug-toxicity complications.
dc.relation.ispartofLife Sciences
dc.titleBenzo(α)pyrene-induced up-regulation of CYP1A2 gene expression: Role of adrenoceptor-linked signaling pathways
elsevier.coverdisplaydate20 June 2006

Files in this item


There are no files associated with this item.

This item appears in the following Collection(s)

Show simple item record